FAM173B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.526000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.832800E-01
Normal-vs-Stage2
8.166600E-01
Normal-vs-Stage3
7.150600E-01
Normal-vs-Stage4
7.606000E-01
Stage1-vs-Stage2
1.037750E-01
Stage1-vs-Stage3
1.736430E-01
Stage1-vs-Stage4
6.814800E-01
Stage2-vs-Stage3
8.734000E-01
Stage2-vs-Stage4
4.349800E-01
Stage3-vs-Stage4
5.707800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.121200E-01
Normal-vs-AfricanAmerican
4.905200E-01
Normal-vs-Asian
9.480400E-01
Caucasian-vs-AfricanAmerican
2.968000E-01
Caucasian-vs-Asian
7.473000E-01
AfricanAmerican-vs-Asian
2.717800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.247000E-01
Normal-vs-Female
8.875800E-01
Male-vs-Female
1.651420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.058600E-01
Normal-vs-Age(41-60Yrs)
7.220600E-01
Normal-vs-Age(61-80Yrs)
8.203800E-01
Normal-vs-Age(81-100Yrs)
8.379600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.039000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.500200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.586000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.935900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.083600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.043200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.723000E-01
Normal-vs-Daily Drinker
9.724400E-01
Normal-vs-Weekly Drinker
8.037400E-01
Normal-vs-Occasional Drinker
5.579200E-01
Normal-vs-Social Drinker
8.868400E-01
Non Drinker-vs-Daily Drinker
2.366600E-01
Non Drinker-vs-Weekly Drinker
4.971700E-02
Non Drinker-vs-Occasional Drinker
1.458390E-02
Non Drinker-vs-Social Drinker
1.956210E-01
Daily Drinker-vs-Weekly Drinker
6.589200E-01
Daily Drinker-vs-Occasional Drinker
2.647800E-01
Daily Drinker-vs-Social Drinker
9.027000E-01
Weekly Drinker-vs-Occasional Drinker
5.097400E-01
Weekly Drinker-vs-Social Drinker
5.153000E-01
Occasional Drinker-vs-Social Drinker
1.859240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.555600E-01
Normal-vs-Grade 2
8.875400E-01
Normal-vs-Grade 3
8.822800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.700200E-01
Grade 1-vs-Grade 3
2.455400E-01
Grade 1-vs-Grade 4
9.555600E-01
Grade 2-vs-Grade 3
8.923800E-01
Grade 2-vs-Grade 4
8.875400E-01
Grade 3-vs-Grade 4
8.822800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.116200E-01
Normal-vs-NonDiabetic
9.938400E-01
Diabetic-vs-NonDiabetic
1.263450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.529400E-01
Normal-vs-NoPancreatitis
9.288600E-01
Pancreatitis-vs-NoPancreatitis
7.445200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.524800E-01
Normal-vs-N1
8.921000E-01
N0-vs-N1
7.894000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.733800E-01
Normal-vs-TP53-NonMutant
7.696800E-01
TP53-Mutant-vs-TP53-NonMutant
6.952600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
